Suchergebnisse - "HORMONE therapy"

All change? The new climacteric market awareness.

Autoren: Takhar, Jennifer Schneider-Kamp, Anna Bettany, Shona

Quelle: Journal of Marketing Management. Mar2025, Vol. 41 Issue 3/4, p237-244. 8p.

Schlagwörter: *CONSUMER behavior, *INFLUENCER marketing, HORMONE therapy, HEALTH behavior, HEALTH self-care, HEALTH literacy

Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Autoren: Patasova, Karina Dehara, Marina Mantel, Ängla et al.

Quelle: Rheumatology. 64(6):3563-3570

Schlagwörter: lupus, menopausal hormone therapy, SSc

Dateibeschreibung: electronic

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-240978
https://doi.org/10.1093/rheumatology/keaf004

Endometrial thickness and pathology in postmenopausal women with bleeding on transdermal 17β-estradiol plus body-identical progesterone.

Autoren: Glynne, Sarah Kamal, Aini Neville, Amy et al.

Quelle: Archives of Gynecology & Obstetrics. Nov2025, Vol. 312 Issue 5, p1705-1717. 13p.

Schlagwörter: *POSTMENOPAUSE, *HORMONE therapy for menopause, *HEMORRHAGE, *PROGESTERONE, *ENDOMETRIAL diseases, *ESTRADIOL, *ENDOMETRIAL surgery, *HORMONE therapy

A review article on transethosomes: revolutionizing drug delivery through transdermal patches.

Autoren: Loni, Siddharam U.S, Suma Zohmingliani, R. et al.

Quelle: Drug Development & Industrial Pharmacy. Jul2025, Vol. 51 Issue 7, p691-701. 11p.

Schlagwörter: TRANSDERMAL medication, HORMONE therapy, INDIVIDUALIZED medicine, DRUG delivery systems, PAIN management, BIOAVAILABILITY, POLYMERSOMES

Gender-affirming interventions and prognosis in multiple sclerosis.

Autoren: Neyal, Nur Nathoo, Nabeela Cathcart-Rake, Elizabeth J et al.

Quelle: Multiple Sclerosis Journal. Dec2025, Vol. 31 Issue 14, p1672-1677. 6p.

Schlagwörter: *MULTIPLE sclerosis, *HORMONE therapy, *TREATMENT effectiveness, *TRANSGENDER people, *GENDER affirming care, *DISEASE progression

Conservative management of enhanced myometrial vascularity (EMV) after a first trimester miscarriage or termination of pregnancy: a retrospective cohort study.

Autoren: Bertucci, Emma Sileo, Filomena Giulia Tramontano, Anna Luna et al.

Quelle: European Journal of Contraception & Reproductive Health Care. Dec2025, Vol. 30 Issue 6, p359-367. 9p.

Schlagwörter: *MISCARRIAGE, *HORMONE therapy, *TREATMENT effectiveness, *COHORT analysis, *WATCHFUL waiting, *UTERINE artery, *ULTRASONIC imaging

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer.

Autoren: Thorat, Mangesh A. Arbyn, Marc Baldwin, David et al.

Quelle: Molecular Oncology. Nov2025, p1. 17p. 4 Illustrations.

Schlagwörter: *HORMONE therapy, *MENOPAUSE, *CONTRACEPTIVES, *HEALTH policy, *ESTROGEN replacement therapy, *CANCER prevention, *ASPIRIN, *DISEASE risk factors

Menopausal Hormone Therapy—Risks, Benefits and Emerging Options: A Narrative Review.

Autoren: Arnautu, Ana Maria Nimigean, Vanda Roxana Nacea-Radu, Claudia Alexandra et al.

Quelle: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 22, p11098. 17p.

Schlagwörter: *HORMONE therapy for menopause, *BONE health, *HOT flashes, *CARDIOVASCULAR diseases risk factors, *INDIVIDUALIZED medicine, *HAZARDS

Cost-effectiveness of single euploid frozen embryo transfer in a true natural versus a hormonal replacement cycle.

Autoren: Marques, Laura Marqueta Van Muylder, Astrid Brijs, Maud et al.

Quelle: Fertility & Sterility. Nov2025:Part 2, Vol. 124 Issue 5, p1032-1041. 10p.

Schlagwörter: *COST effectiveness, *HORMONE therapy, *FERTILITY, *MISCARRIAGE, *EMBRYO transfer

Validity of completely omitting endocrine and ultrasound monitoring in hormone replacement therapy protocols for frozen embryo transfer in good-prognosis patients undergoing single blastocyst transfer.

Autoren: Asoglu, Mehmet Resit Bozdag, Gurkan Ozturk, Ebru et al.

Quelle: Fertility & Sterility. Nov2025:Part 2, Vol. 124 Issue 5, p1024-1031. 8p.

Schlagwörter: *HORMONE therapy, *EMBRYO transfer, *PROGNOSIS, *HUMAN embryo transfer, *PATIENT monitoring, *DIAGNOSTIC ultrasonic imaging, *FERTILIZATION in vitro

Premature Ovarian Insufficiency and Diminished Ovarian Reserve: From Diagnosis to Current Management and Treatment.

Autoren: Houeis, Lara Donnez, Jacques Dolmans, Marie-Madeleine

Quelle: Journal of Clinical Medicine. Nov2025, Vol. 14 Issue 21, p7473. 16p.

Schlagwörter: *OVARIAN reserve, *HORMONE therapy, *CONTROL groups, *THERAPEUTICS, *FERTILITY preservation, *PREMATURE ovarian failure, *DIAGNOSIS

The Role of Growth Hormone-Releasing Hormone and the Hypothalamic–Pituitary–Somatotropic Axis in Aging: Potential Therapeutic Applications and Risks.

Autoren: Oikonomakos, Ioannis Siow, Richard Bornstein, Stefan R. et al.

Quelle: Hormone & Metabolic Research. Nov2025, Vol. 57 Issue 11, p662-667. 6p.

Schlagwörter: *AGING, *HORMONE therapy, *TREATMENT effectiveness, *GROWTH hormone releasing factor, *AGE factors in disease, *HYPOTHALAMIC-pituitary-adrenal axis, *SOMATOTROPIN, *HAZARDS

Age‐Associated Inflammatory Monocytes Are Increased in Menopausal Females and Reversed by Hormone Replacement Therapy.

Autoren: De Maeyer, R. P. H. Sikora, J. Bracken, O. V. et al.

Quelle: Aging Cell. Nov2025, Vol. 24 Issue 11, p1-13. 13p.

Schlagwörter: *MENOPAUSE, *HORMONE therapy, *PHAGOCYTOSIS, *IMMUNE response, *MONOCYTES, *CELLULAR immunity

Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studies.

Autoren: Santucci, Jordan Stapleton, Peter Perera, Marlon et al.

Quelle: BJU International. Nov2025, Vol. 136 Issue 5, p788-799. 12p.

Schlagwörter: *PROSTATE cancer, *HORMONE therapy, *PATIENT monitoring, *HYPOGONADISM, *DISEASE relapse, *WATCHFUL waiting, *PATIENT safety

Clinical Predictors of Response to Testosterone Replacement Therapy in Boys With Micropenis: A Retrospective Study Focusing on Penile Morphology and Hormonal Factors.

Autoren: Harada, Junki Mitsunari, Kensuke Kakita, Shota et al.

Quelle: International Journal of Urology. Nov2025, Vol. 32 Issue 11, p1670-1676. 7p.

Schlagwörter: *HORMONE therapy, *PENIS size, *TREATMENT effectiveness, *PENIS diseases, *BIOMARKERS, *BOYS, *ENDOCRINE diseases, *RETROSPECTIVE studies

Opioid‐induced androgen deficiency in men: Prevalence, pathophysiology, and efficacy of testosterone therapy.

Autoren: Kafel, Hussein Braga‐Basaria, Milena Basaria, Shehzad

Quelle: Andrology. Nov2025, Vol. 13 Issue 8, p2010-2021. 12p.

Schlagwörter: *HYPOGONADISM, *HORMONE therapy, *PAIN management, *GONADOTROPIN releasing hormone, *CHRONIC pain

Cardiac function and coronary plaque development following masculinizing gender‐affirming hormone therapy: A prospective cohort study.

Autoren: Buhl, Laust Frisenberg Andersen, Marianne S. Frystyk, Jan et al.

Quelle: Andrology. Nov2025, Vol. 13 Issue 8, p2195-2205. 11p.

Schlagwörter: *HORMONE therapy, *CARDIOVASCULAR diseases risk factors, *CARDIAC output, *ATHEROSCLEROTIC plaque, *GENDER-nonconforming people, *DIASTOLIC blood pressure, *ECHOCARDIOGRAPHY

Exploring the availability and acceptability of hormone replacement therapy in LMICs using insights of pharmacists (MARIE Sri Lanka WP2a).

Autoren: Pathiraja, Vindya Kurmi, Om Toh, Teck-Hock et al.

Quelle: Scientific Reports. 10/30/2025, Vol. 15 Issue 1, p1-10. 10p.

Schlagwörter: *HORMONE therapy, *MENOPAUSE, *LOW-income countries, *HEALTH literacy, *WOMEN'S health, *HEALTH services accessibility, *PHARMACISTS, *PRICE sensitivity

Geografische Kategorien: SRI Lanka, NEPAL

Systemic Estrogen Therapy Is Associated With Lower Surgical Intervention Rates for Nasal Obstruction.

Autoren: Oliver, Jamie R. Wang, Naomi C. VandeVelde, Cole W. et al.

Quelle: International Forum of Allergy & Rhinology. Oct2025, p1. 4p.

Schlagwörter: *ESTROGEN replacement therapy, *HORMONE therapy, *NASAL surgery, *RESPIRATORY obstructions, *POSTMENOPAUSE

A visual whole-body tumor-burden classification based on PSMA PET/CT to predict response to novel androgen receptor signaling inhibitors for metastatic hormone-sensitive prostate cancer patients.

Autoren: Liao, Xuhe Li, Shanshi Sun, Hongwei et al.

Quelle: European Journal of Nuclear Medicine & Molecular Imaging. Oct2025, Vol. 52 Issue 12, p4399-4413. 15p.

Schlagwörter: *PROSTATE cancer, *HORMONE therapy, *PROSTATE-specific antigen, *PATIENT care, *TUMOR classification, *ANDROGEN receptors, *METASTASIS, *COMPUTER-assisted image analysis (Medicine)